Saint Vincent and the Grenadines vs Switzerland: Tuberculosis treatment success rate
Saint Vincent and the Grenadines
60.0%
in 2022
Switzerland
58.0%
in 2023
Saint Vincent and the Grenadines rank
183rd
Switzerland rank
185th
Tuberculosis treatment success rate over time
- Saint Vincent and the Grenadines
- Switzerland
How they compare
Saint Vincent and the Grenadines currently reports 60.0% against 58.0% in Switzerland, a difference of 2.0%.
The two have swapped places 2 times across 7 shared years of data; in 2016 it was Switzerland ahead.
Saint Vincent and the Grenadines ranks 183rd and Switzerland ranks 185th of 206 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Vincent and the Grenadines | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.8% | 74.0% | 7.2% | Switzerland |
| 2020s | 55.3% | 71.3% | 16.0% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Saint Vincent and the Grenadines or Switzerland?
- Saint Vincent and the Grenadines, at 60.0% against 58.0% in Switzerland as of 2022.
- What is the difference in tuberculosis treatment success rate between Saint Vincent and the Grenadines and Switzerland?
- 2.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Saint Vincent and the Grenadines and Switzerland?
- 7 years are reported by both, from 2016 to 2022.
- How do Saint Vincent and the Grenadines and Switzerland rank globally for tuberculosis treatment success rate?
- Saint Vincent and the Grenadines ranks 183rd and Switzerland ranks 185th of 206 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.